olomoucine has been researched along with Stomach Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hellmich, MR; Iseki, H; Ko, TC; Seapan, A; Townsend, CM; Xue, XY | 1 |
Atienza, C; Dong, YB; Elliott, MJ; Liu, TJ; McMasters, KM; Stilwell, A; Yang, HL | 1 |
Bang, YJ; Hong, SH; Jong, HS; Kim, NK; Kim, SG; Kim, SJ; Kim, SN | 1 |
3 other study(ies) available for olomoucine and Stomach Neoplasms
Article | Year |
---|---|
Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells.
Topics: Antineoplastic Agents; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; Histones; Humans; Kinetics; Kinetin; Protein Serine-Threonine Kinases; Purines; Roscovitine; Stomach Neoplasms; Substrate Specificity; Tumor Cells, Cultured | 1997 |
Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
Topics: Adenoviridae; Apoptosis; bcl-2-Associated X Protein; Carrier Proteins; Caspases; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Inhibitors; Gene Transfer Techniques; Humans; Kinetin; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Purines; Retinoblastoma-Binding Protein 1; Roscovitine; Stomach Neoplasms; Transcription Factor DP1; Transcription Factors; Tumor Cells, Cultured | 2000 |
Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Topics: Annexin A5; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Kinetin; Microtubule-Associated Proteins; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Purines; Retinoblastoma Protein; RNA, Messenger; Roscovitine; Stomach Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |